ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.

Jiang, Xianjie; Wang, Jie; Deng, Xiangying; Xiong, Fang; Ge, Junshang; Xiang, Bo; Wu, Xu; Ma, Jian; Zhou, Ming; Li, Xiaoling; Li, Yong; Li, Guiyuan; Xiong, Wei; Guo, Can*; Zeng, Zhaoyang*湖南省肿瘤医院; University of North Dakota
Molecular Cancer2019-1-15DOI: 10.1186/s12943-018-0928-4
14阅读
引用收藏
分享

摘要

Tumor immune escape is an important strategy of tumor survival. There are many mechanisms of tumor immune escape, including immunosuppression, which has become a research hotspot in recent years. The programmed death ligand-1/programmed death-1 (PD-L1/PD-1) signaling pathway is an important component of tumor immunosuppression, which can inhibit the activation of T lymphocytes and enhance the immune tolerance of tumor cells, thereby achieving tumor immune escape. Therefore, targeting the PD-L1/PD-1 pathway is an attractive strategy for cancer treatment; however, the therapeutic effectiveness of PD-L1/PD-1 remains poor. This situation requires gaining a deeper understanding of the complex and varied molecular mechanisms and factors driving the expression and activation of the PD-L1/PD-1 signaling pathway. In this review, we summarize the regulation mechanisms of the PD-L1/PD-1 signaling pathway in the tumor microenvironment and their roles in mediating tumor escape. Overall, the evidence accumulated to date suggests that induction of PD-L1 by inflammatory factors in the tumor microenvironment may be one of the most important factors affecting the therapeutic efficiency of PD-L1/PD-1 blocking.

学科与关键词

关键词
Inflammatory factorPD-1PD-L1Tumor immune escapeTumor microenvironment
相关
加载中…
  • The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
    Tang, Qing; Chen, Yun; Li, Xiaojuan; Long, Shunqin; Shi, Yao; Yu, Yaya; Wu, Wanyin*; Han, Ling*; Wang, Sumei*Frontiers in Immunology, 2022, 13: 964442.被引 57
  • Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape.
    Li, Zhengshuo; Wang, Jing; Zhang, Xuemei; Liu, Peishan; Zhang, Xiaoyue; Wang, Jia; Zheng, Xiang; Wei, Lingyu; Peng, Qiu; Liu, Can; Yan, Qun; Shen, Shourong; Li, Xiayu; Ma, Jian*Journal of Immunology, 2020, 204(9): 2589-2599.
  • 简述影响肿瘤PD-L1表达的各种因素
    柯佳; 李卓伟; 杨慧科; 吕晓红; 张雅芳; 李雪梅解剖科学进展, 2019, (06): 704-706.
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Cancer
发表日期
2019-01-15
卷期
第 18 卷, 第 1 期
页码
10
DOI
10.1186/s12943-018-0928-4
语言
ENGLISH
成果收录
PUBMED

作者

  • J

    Jiang, Xianjie (第一作者)

    hunan cancer hospital

  • W

    Wang, Jie

查看全部 15 位作者收起作者
  • D

    Deng, Xiangying

  • X

    Xiong, Fang

  • G

    Ge, Junshang

    hunan cancer hospital

  • X

    Xiang, Bo

    hunan cancer hospital

  • W

    Wu, Xu

    university of north dakota

  • M

    Ma, Jian

    hunan cancer hospital

  • Z

    Zhou, Ming

    hunan cancer hospital

  • L

    Li, Xiaoling

    hunan cancer hospital

  • L

    Li, Yong

  • L

    Li, Guiyuan

    hunan cancer hospital

  • X

    Xiong, Wei

    hunan cancer hospital

  • G

    Guo, Can (通讯)

    hunan cancer hospital

  • Z

    Zeng, Zhaoyang (通讯)

    hunan cancer hospital

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417